{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:54:31Z","timestamp":1759694071841,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["2020\/LNCC\/35"],"award-info":[{"award-number":["2020\/LNCC\/35"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2022,11,23]]},"DOI":"10.1038\/s41416-022-01985-2","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T21:02:57Z","timestamp":1664485377000},"page":"1954-1962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mutation of the proline P81 into a serine modifies the tumour suppressor function of the von Hippel\u2013Lindau gene in the ccRCC"],"prefix":"10.1038","volume":"127","author":[{"given":"Franck","family":"Chesnel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Jullion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Delalande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Couturier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Alusse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Lenglet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty","family":"Gardie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1425-6926","authenticated-orcid":false,"given":"Caroline","family":"Abadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4633-5650","authenticated-orcid":false,"given":"Yannick","family":"Arlot-Bonnemains","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"1985_CR1","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/sj.onc.1207384","volume":"23","author":"MD Lewis","year":"2004","unstructured":"Lewis MD, Roberts BJ. Role of the C-terminal \u03b1-helical domain of the von Hippel\u2013Lindau protein in its E3 ubiquitin ligase activity. Oncogene. 2004;23:2315\u201323.","journal-title":"Oncogene"},{"key":"1985_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1535-6108(02)00044-2","volume":"1","author":"JK Maranchie","year":"2002","unstructured":"Maranchie JK, Vasselli JR, Riss J, Bonifacino JS, Linehan WM, Klausner RD. The contribution of VHL substrate binding and HIF1-\u03b1 to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell. 2002;1:247\u201355.","journal-title":"Cancer Cell"},{"key":"1985_CR3","first-page":"521","volume":"31","author":"M Nordstrom-O\u2019Brien","year":"2010","unstructured":"Nordstrom-O\u2019Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, et al. Genetic analysis of von Hippel-Lindau disease. Hum Mutat. 2010;31:521\u201337.","journal-title":"Hum Mutat."},{"key":"1985_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","volume":"8","author":"B Zbar","year":"1996","unstructured":"Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, et al. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat. 1996;8:348\u201357.","journal-title":"Hum Mutat"},{"key":"1985_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1182\/blood-2018-03-838235","volume":"132","author":"M Lenglet","year":"2018","unstructured":"Lenglet M, Robriquet F, Schwarz K, Camps C, Couturier A, Hoogewijs D, et al. Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease. Blood. 2018;132:469\u201383.","journal-title":"Blood"},{"key":"1985_CR6","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1016\/j.febslet.2009.10.070","volume":"583","author":"E Leonardi","year":"2009","unstructured":"Leonardi E, Murgia A, Tosatto SCE. Adding structural information to the von Hippel-Lindau (VHL) tumor suppressor interaction network. FEBS Lett. 2009;583:3704\u201310.","journal-title":"FEBS Lett"},{"key":"1985_CR7","doi-asserted-by":"publisher","first-page":"e1006478","DOI":"10.1371\/journal.pcbi.1006478","volume":"15","author":"G Minervini","year":"2019","unstructured":"Minervini G, Quaglia F, Tabaro F, Tosatto SCE. Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors. PLoS Comput Biol. 2019;15:e1006478.","journal-title":"PLoS Comput Biol"},{"key":"1985_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0959-437X(00)00152-0","volume":"11","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kaelin WG. The von Hippel\u2013Lindau tumor suppressor protein. Curr Opin Genet Dev. 2001;11:27\u201334.","journal-title":"Curr Opin Genet Dev"},{"key":"1985_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/jmg.37.12.939","volume":"37","author":"FJ Hes","year":"2000","unstructured":"Hes FJ. Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only. J Med Genet. 2000;37:939\u201343.","journal-title":"J Med Genet."},{"key":"1985_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2174\/1389202917666160805153221","volume":"18","author":"D Alosi","year":"2016","unstructured":"Alosi D, Bisgaard M, Hemmingsen S, Krogh L, Mikkelsen H, Binderup M. Management of gene variants of unknown significance: analysis method and risk assessment of the VHL mutation p.P81S (c.241C>T). Curr Genomics. 2016;18:93\u2013103.","journal-title":"Curr Genomics"},{"key":"1985_CR11","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1074\/jbc.M809056200","volume":"284","author":"K Knauth","year":"2009","unstructured":"Knauth K, Cartwright E, Freund S, Bycroft M, Buchberger A. VHL mutations linked to Type 2C von Hippel-Lindau disease cause extensive structural perturbations in pVHL. J Biol Chem. 2009;284:10514\u201322.","journal-title":"J Biol Chem"},{"key":"1985_CR12","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/jnci\/djt226","volume":"105","author":"MC DeSimone","year":"2013","unstructured":"DeSimone MC, Rathmell WK, Threadgill DW. Pleiotropic effects of the trichloroethylene-associated P81S VHL mutation on metabolism, apoptosis, and ATM-mediated DNA damage response. J Natl Cancer Inst. 2013;105:1355\u201364.","journal-title":"J Natl Cancer Inst"},{"key":"1985_CR13","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1210\/jc.2002-020651","volume":"87","author":"G Weirich","year":"2002","unstructured":"Weirich G, Klein B, W\u00f6hl T, Engelhardt D, Brauch H. VHL2C phenotype in a German von Hippel-Lindau family with concurrent VHL germline mutations P81S and L188V. J Clin Endocrinol Metab. 2002;87:5241\u20136.","journal-title":"J Clin Endocrinol Metab."},{"key":"1985_CR14","doi-asserted-by":"publisher","first-page":"75989","DOI":"10.18632\/oncotarget.18376","volume":"8","author":"P Hascoet","year":"2017","unstructured":"Hascoet P, Chesnel F, Jouan F, Goff CL, Couturier A, Darrigrand E, et al. The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13. Oncotarget. 2017;8:75989\u20136002.","journal-title":"Oncotarget"},{"key":"1985_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/bjc.2015.189","volume":"113","author":"F Chesnel","year":"2015","unstructured":"Chesnel F, Hascoet P, Gagne JP, Couturier A, Jouan F, Poirier GG, et al. The von Hippel-Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform. Br J Cancer. 2015;113:336\u201344.","journal-title":"Br J Cancer"},{"key":"1985_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.gde.2006.12.006","volume":"17","author":"JD Gordan","year":"2007","unstructured":"Gordan JD, Simon MC. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev. 2007;17:71\u20137.","journal-title":"Curr Opin Genet Dev."},{"key":"1985_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/humu.20082","volume":"24","author":"C Gallou","year":"2004","unstructured":"Gallou C, Chauveau D, Richard S, Joly D, Giraud S, Olschwang S, et al. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Hum Mutat. 2004;24:215\u201324.","journal-title":"Hum Mutat."},{"key":"1985_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ng0594-85","volume":"7","author":"JR Gnarra","year":"1994","unstructured":"Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet. 1994;7:85\u201390.","journal-title":"Nat Genet"},{"key":"1985_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.toxlet.2003.12.074","volume":"151","author":"H Brauch","year":"2004","unstructured":"Brauch H, Weirich G, Klein B, Rabstein S, Bolt HM, Br\u00fcning T. VHL mutations in renal cell cancer: does occupational exposure to trichloroethylene make a difference? Toxicol Lett. 2004;151:301\u201310.","journal-title":"Toxicol Lett"},{"key":"1985_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.284.5413.455","volume":"284","author":"CE Stebbins","year":"1999","unstructured":"Stebbins CE. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science. 1999;284:455\u201361.","journal-title":"Science."},{"key":"1985_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.str.2014.12.014","volume":"23","author":"HC Nguyen","year":"2015","unstructured":"Nguyen HC, Yang H, Fribourgh JL, Wolfe LS, Xiong Y. Insights into Cullin-RING E3 ubiquitin ligase recruitment: structure of the VHL-EloBC-Cul2 complex. Structure. 2015;23:441\u20139.","journal-title":"Structure."},{"key":"1985_CR22","doi-asserted-by":"publisher","first-page":"200109","DOI":"10.1098\/rsob.200109","volume":"10","author":"G Minervini","year":"2020","unstructured":"Minervini G, Pennuto M, Tosatto SCE. The pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer. Open Biol. 2020;10:200109.","journal-title":"Open Biol"},{"key":"1985_CR23","doi-asserted-by":"publisher","first-page":"13264","DOI":"10.1074\/jbc.M611648200","volume":"282","author":"A Grosfeld","year":"2007","unstructured":"Grosfeld A, Stolze IP, Cockman ME, Pugh CW, Edelmann M, Kessler B, et al. Interaction of hydroxylated collagen IV with the von Hippel-Lindau tumor suppressor. J Biol Chem. 2007;282:13264\u20139.","journal-title":"J Biol Chem."},{"key":"1985_CR24","doi-asserted-by":"publisher","first-page":"14531","DOI":"10.1073\/pnas.0606850103","volume":"103","author":"B Peruzzi","year":"2006","unstructured":"Peruzzi B, Athauda G, Bottaro DP. The von Hippel\u2013Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells. Proc Natl Acad Sci USA. 2006;103:14531\u20136.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1985_CR25","doi-asserted-by":"publisher","first-page":"598656","DOI":"10.3389\/fendo.2021.598656","volume":"12","author":"S Gao","year":"2021","unstructured":"Gao S, Liu L, Li Z, Pang Y, Shi J, Zhu F. Seven novel genes related to cell proliferation and migration of VHL-mutated pheochromocytoma,. Front Endocrinol. 2021;12:598656.","journal-title":"Front Endocrinol."},{"key":"1985_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/humu.1380050109","volume":"5","author":"F Chen","year":"1995","unstructured":"Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, et al. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat. 1995;5:66\u201375.","journal-title":"Hum Mutat."},{"key":"1985_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/humu.20385","volume":"28","author":"KR Ong","year":"2007","unstructured":"Ong KR, Woodward ER, Killick P, Lim C, Macdonald F, Maher ER. Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat. 2007;28:143\u20139.","journal-title":"Hum Mutat."},{"key":"1985_CR28","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1158\/0008-5472.CAN-05-2670","volume":"66","author":"MA Esteban","year":"2006","unstructured":"Esteban MA, Tran MGB, Harten SK, Hill P, Castellanos MC, Chandra A, et al. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res. 2006;66:3567\u201375.","journal-title":"Cancer Res"},{"key":"1985_CR29","doi-asserted-by":"publisher","first-page":"e67071","DOI":"10.1371\/journal.pone.0067071","volume":"8","author":"B Martin","year":"2013","unstructured":"Martin B, Chesnel F, Delcros JG, Jouan F, Couturier A, Dugay F, et al. Identification of pVHL as a novel substrate for Aurora-A in clear cell renal cell carcinoma (ccRCC). PLoS ONE. 2013;8:e67071.","journal-title":"PLoS ONE."},{"key":"1985_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41431-020-00755-z","volume":"29","author":"D Baux","year":"2021","unstructured":"Baux D, Van Goethem C, Ardouin O, Guignard T, Bergougnoux A, Koenig M, et al. MobiDetails: online DNA variants interpretation. Eur J Hum Genet. 2021;29:356\u201360.","journal-title":"Eur J Hum Genet."},{"key":"1985_CR31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.23892","volume":"40","author":"L Wiel","year":"2019","unstructured":"Wiel L, Baakman C, Gilissen D, Veltman JA, Vriend G, Gilissen C. Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains. Hum Mutat. 2019;40:1030\u20138.","journal-title":"Hum Mutat."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01985-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01985-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01985-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:15:03Z","timestamp":1669162503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01985-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,23]]}},"alternative-id":["1985"],"URL":"https:\/\/doi.org\/10.1038\/s41416-022-01985-2","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"type":"print","value":"0007-0920"},{"type":"electronic","value":"1532-1827"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"24 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}